These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33843883)

  • 1. Highlights in B-cell malignancies from the 61st American Society of Hematology Annual Meeting: commentary.
    Furman RR
    Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 8(2):24-26. PubMed ID: 33843883
    [No Abstract]   [Full Text] [Related]  

  • 2. Highlights in B-cell malignancies from the 61st American Society of Hematology Annual Meeting.
    Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 8(2):1-28. PubMed ID: 33843882
    [No Abstract]   [Full Text] [Related]  

  • 3. Highlights in chronic lymphocytic leukemia from the 61st American Society of Hematology Annual Meeting and Exposition: commentary.
    Awan FT
    Clin Adv Hematol Oncol; 2020 Jan; 18 Suppl 3(1):14-17. PubMed ID: 33843856
    [No Abstract]   [Full Text] [Related]  

  • 4. Highlights in myelodysplastic syndromes from the 61st American Society of Hematology Annual Meeting: commentary.
    Garcia-Manero G
    Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 5(2):18-22. PubMed ID: 33843920
    [No Abstract]   [Full Text] [Related]  

  • 5. Highlights in Hodgkin lymphoma from the 61st American Society of Hematology Annual Meeting: commentary.
    Straus DJ
    Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 6(2):20-23. PubMed ID: 33843910
    [No Abstract]   [Full Text] [Related]  

  • 6. Highlights in CAR T-cell therapy from the 61st American Society of Hematology Annual Meeting: commentary.
    Jacobson CA
    Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 7(2):20-23. PubMed ID: 33843872
    [No Abstract]   [Full Text] [Related]  

  • 7. Highlights in chronic lymphocytic leukemia from the 61st American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2020 Jan; 18 Suppl 3(1):1-20. PubMed ID: 33843855
    [No Abstract]   [Full Text] [Related]  

  • 8. Highlights in CAR T-cell therapy from the 61st American Society of Hematology Annual Meeting.
    Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 7(2):1-24. PubMed ID: 33843871
    [No Abstract]   [Full Text] [Related]  

  • 9. Highlights in myelodysplastic syndromes from the 61st American Society of Hematology Annual Meeting.
    Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 5(2):1-24. PubMed ID: 33843919
    [No Abstract]   [Full Text] [Related]  

  • 10. Highlights in Hodgkin lymphoma from the 61st American Society of Hematology Annual Meeting.
    Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 6(2):1-24. PubMed ID: 33843909
    [No Abstract]   [Full Text] [Related]  

  • 11. American society of hematology-45th annual meeting and exposition: hematological malignancies.
    Davies J
    IDrugs; 2004 Jan; 7(1):1-3. PubMed ID: 14968766
    [No Abstract]   [Full Text] [Related]  

  • 12. Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Davids MS
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 4(1):21-23. PubMed ID: 33843888
    [No Abstract]   [Full Text] [Related]  

  • 13. Highlights in CAR T-cell therapy from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Jacobson CA
    Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 10(3):19-23. PubMed ID: 33843918
    [No Abstract]   [Full Text] [Related]  

  • 14. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Evens AM
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):20-23. PubMed ID: 33843922
    [No Abstract]   [Full Text] [Related]  

  • 15. Highlights in myelodysplastic syndromes from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Garcia-Manero G
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 5(1):20-23. PubMed ID: 33843866
    [No Abstract]   [Full Text] [Related]  

  • 16. Summer happenings in Hematology 2011. Highlights in Hematological Malignancies form the 2011 American Society Clinical Oncology Annual Meeting and the 16th Congress of the European Hematology Association, and the 11th International Conference on Malignancy Lymphoma.
    Ashforth E; Cheson BD
    Clin Adv Hematol Oncol; 2011 Aug; 9(8 Suppl 17):1-24. PubMed ID: 22361949
    [No Abstract]   [Full Text] [Related]  

  • 17. Highlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Barr PM
    Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 11(3):17-19. PubMed ID: 33843916
    [No Abstract]   [Full Text] [Related]  

  • 18. Highlights in relapsed/refractory follicular lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Salles G
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 2(1):13-16. PubMed ID: 33843858
    [No Abstract]   [Full Text] [Related]  

  • 19. Highlights in chronic graft-vs-host disease from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    DiPersio JF
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 8(2):20-23. PubMed ID: 33843914
    [No Abstract]   [Full Text] [Related]  

  • 20. The 51st annual meeting of the American Society of Hematology.
    Muneer S; Ranganathan A; Schlager S;
    Clin Lymphoma Myeloma Leuk; 2010 Apr; 10(2):90-7. PubMed ID: 20371441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.